11/20
12:50 pm
rxrx
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
Medium
Report
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
11/20
12:32 pm
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
11/20
12:32 pm
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
11/7
08:36 am
rxrx
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
Low
Report
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
11/7
07:24 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
11/7
07:24 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
9/4
06:21 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
9/4
06:21 am
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
9/3
01:37 pm
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
9/3
01:37 pm
rxrx
Rating for RXRX
Low
Report
Rating for RXRX
9/3
01:35 pm
rxrx
Rating for RXRX
Low
Report
Rating for RXRX